BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $20,920,000 | +734.1% | 1,510,473 | +852.3% | 1.22% | +742.8% |
| Q2 2021 | $2,508,000 | -34.9% | 158,609 | -58.1% | 0.14% | -37.5% |
| Q1 2021 | $3,852,000 | -54.0% | 378,774 | -66.3% | 0.23% | -53.4% |
| Q4 2020 | $8,365,000 | +207.0% | 1,122,800 | +41.6% | 0.50% | +146.5% |
| Q3 2020 | $2,725,000 | -57.9% | 793,054 | -41.6% | 0.20% | -50.5% |
| Q2 2020 | $6,470,000 | +296.4% | 1,357,848 | +66.5% | 0.41% | +170.2% |
| Q1 2020 | $1,632,000 | -78.0% | 815,690 | -62.1% | 0.15% | -71.8% |
| Q4 2019 | $7,421,000 | +401.1% | 2,151,164 | +316.3% | 0.54% | +299.3% |
| Q3 2019 | $1,481,000 | -8.4% | 516,734 | +21.2% | 0.13% | -9.5% |
| Q2 2019 | $1,616,000 | – | 426,400 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |